Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | SDCBP | O00560 | 1/20 | 0.38 |
| ▸ | SDC2 | P34741 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.37 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.36 |
| ▸ | RELA | Q04206 | 1/20 | 0.36 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.36 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.36 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8348656 | 0.91 | HSP90AA1 (0.36) | L3MBTL1SDCBPSDC2HSP90AA1KCNH2 | |
| SCHEMBL6787040 | 0.85 | SLC6A4 (0.36) | L3MBTL1SDCBPSDC2SMN1; SMN2SSTR4 | |
| SCHEMBL3858652 | 0.79 | HDAC3 (0.46) | SMN1; SMN2SSTR4RAB9ANPC1KMT2A | |
| SCHEMBL8348739 | 0.77 | SLC6A4 (0.36) | L3MBTL1SDCBPSDC2SSTR4RAB9A | |
| SCHEMBL8344651 | 0.76 | CYP19A1 (0.38) | ALDH1A1MAPT | |
| SCHEMBL2579003 | 0.75 | CA14 (0.42) | L3MBTL1SSTR4KMT2ALMNAMEN1 | |
| SCHEMBL7016547 | 0.74 | HSP90AA1 (0.50) | L3MBTL1SDCBPSDC2HSP90AA1KCNH2 | |
| SCHEMBL24483689 | 0.72 | ALDH1A1 (0.39) | L3MBTL1SMN1; SMN2RAB9ANPC1NFKB1 | |
| SCHEMBL2929114 | 0.72 | MLYCD (0.38) | HSP90AA1SMN1; SMN2RAB9ANPC1KMT2A | |
| SCHEMBL203927 | 0.72 | SSTR4 (0.32) | L3MBTL1SMN1; SMN2SSTR4RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040092498-A1 | Substituted glycine derivatives for use as medicaments | BLAKEMORE DAVID (GB) | 2004-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092498-A1 | Substituted glycine derivatives for use as medicaments | GLRA1, GRM1, GPR6 | L3MBTL1 1002/4885SDCBP 1058/4885SDC2 685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.